The PennZone

  • Home
  • Music
  • Entertainment
  • Marketing
  • Education
  • Non-profit
  • Technology
  • Event
  • Books

DG Meditech Opens Doors to North American Operations With Appointment of New Chief for Americas
The PennZone/10148921

Trending...
  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 234
  • KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
  • Mumbai Central Farmers Market Launches Community Collective for More Value and Connection
DGMeditech
TRAVERSE CITY, Mich. & TORONTO - PennZone -- The DG Meditech today announced the appointment of Davis Gravelsins as Chief Executive Officer, US Operations. Previously working as Senior Liaison Digital Transition - Healthcare on projects in the Baltic and in the E.U., Mr. Gravelsins will now be heading up DG Meditech's service expansion into North and South American geographies.

Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.

Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.

More on The PennZone
  • Phinge Exposes Massive AI Security Flaws, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
  • Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
  • Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
  • DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion

Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.

The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.

"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.

-        30  –

For more information, please contact us:

Toronto, Canada Office: Mr. D. Gravelsins

davis.gravelsins@dgmeditech.com

Travers City Office: Mr. J. Anson

janson@dgmeditech.com – 705-943-8225

Contact
Davis Gravelsins
***@dgmeditech.com


Source: DGMeditech

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Fit Body Boot Camp Launches Nationwide 'Fit Body Forever' Workshops to Help Adults 60+ Rebuild Strength and Prevent Falls
  • Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
  • 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
  • Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
  • Hollywood In Pixels Announces Honorees for The 9th Silver PIXel Awards
  • New Research Finds a Good Deal Is All It Takes to Get Americans Booking a Last-Minute Vacation — and Most Already Have One on Their Mind
  • GitKraken Introduces GitLens 19, Bringing Human and AI Workflows Together in One Workbench
  • LĪNA Universal Balm Nominated for "Best Clean Skincare Product" at CertClean Beauty Awards
  • Bronze Stevie Award Recognizes Satyadhar Joshi for AI Research and Public Policy Engagement
  • synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
  • Leading PDR Training Courses in Canada: Learn Paintless Dent Repair with PDR Academy & Tint Academy
  • Move in this Fall! New Released Quick Move-In Townhomes at Heritage at South Brunswick with Limited-Time Incentives
  • Rebecca L. Francis, Founder of the Rebecca Francis Team, Named to Lehigh Valley Business' LVB 300
  • Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
  • Imagen Golf & Top 100 Coach Daniel Guest Voted Best Golf Instruction Firm of the Year 2026
  • Q1 2026 Arizona Technology Industry Impact Report Recaps Advanced Manufacturing Growth, High-Value Jobs and Workforce Investment
  • Former Prosecutor Opens Stegall Law in Summerville
  • Vboost Celebrates 14 years of Automotive Viral Marketing
  • M.C. Weeks, Inc. Marks 80 Years of Family Ownership and Brand Refresh
  • Ignazio Arces Wins Stevie® Award for Maverick of the Year at the 2026 International Business Awards

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 234
  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board - 108
  • Philadelphia Community Invited to Unite for Praise-A-Thon Summer Concert Benefiting Cobbs Creek
  • The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
  • Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
  • Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
  • New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
  • Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC)

Similar on PennZone

  • DuraFast Label Company Launches Seiko SLP850 2" Thermal Printer with Free Label Promotion
  • Canadian Aerospace Defence Talent Expo (CADTE) Launches National TalentThread Initiative to Strengthen Canada's Future Workforce
  • synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
  • Crossroads4Hope Marks 25 Years Ensuring No One Faces Cancer Alone At its Inspiring Hope Gala
  • KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
  • Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
  • Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
  • Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
  • Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
  • FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us